Skip to main content

Advertisement

SpringerLink
Log in

Impact of Neurogenic Lower Urinary Tract Dysfunction on Bowel Symptoms

  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of review

In this review, the current literature available to patients and providers regarding neurogenic bowel dysfunction as it relates to the treatment of neurogenic bladder dysfunction will be addressed. Topics include the common pathophysiologic pathways, and the management of fecal incontinence and constipation that can occur simultaneously with urinary incontinence or retention, or which may result from the treatment of urinary incontinence or retention.

Recent findings

The availability of newer pharmacotherapeutics, and the adoption of chemodenervation, nerve stimulation and neuromodulation has added to the armamentarium that providers have for treating this difficult clinical constellation. And while there have not been dramatic advances in the surgical management of neurogenic bladder, our understanding of the side effects of surgery continues to evolve.

Summary

Until there is a cure for traumatic and other acquired myelopathies, the urologist remains the specialist best suited to manage the subsequent urinary retention and incontinence. Virtually all interventions can have an effect, either ameliorative or adverse on the symptoms and management of concomitant neurogenic bowel dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Burns AS, St-Germain D, Connolly M, Delparte JJ, Guindon A, Hitzig SL, et al. Phenomenological study of neurogenic bowel from the perspective of individuals living with spinal cord injury. Arch Phys Med Rehabil. 2015;96(1):49–55.e1.

    Article  PubMed  Google Scholar 

  2. Pardee C, Bricker D, Rundquist J, MacRae C, Tebben C. Characteristics of neurogenic bowel in spinal cord injury and perceived quality of life. Rehabil Nurs. 2012;37(3):128–35.

    Article  PubMed  Google Scholar 

  3. Cardenas DD, Hoffman JM, Kirshblum S, McKinley W. Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated. Arch Phys Med Rehabil. 2004;85(11):1757–63.

    Article  PubMed  Google Scholar 

  4. Pires JM, Ferreira AM, Rocha F, Andrade LG, Campos I, Margalho P, et al. Assessment of neurogenic bowel dysfunction impact after spinal cord injury using the International Classification of Functioning, Disability and Health. Eur J Phys Rehabil Med. 2019;54(6) https://www.minervamedica.it/index2.php?show=R33Y2018N06A0873

  5. Inskip JA, Lucci VEM, McGrath MS, Willms R, Claydon VE. A community perspective on bowel management and quality of life after spinal cord injury: the influence of autonomic dysreflexia. J Neurotrauma. 2018 May;35(9):1091–105.

    Article  PubMed  PubMed Central  Google Scholar 

  6. the SCIRE Research Team, Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord. 2010;48(10):718–33.

    Article  PubMed Central  Google Scholar 

  7. Savic G, DeVivo MJ, Frankel HL, Jamous MA, Soni BM, Charlifue S. Causes of death after traumatic spinal cord injury—a 70-year British study. Spinal Cord. 2017;55(10):891–7.

    Article  CAS  PubMed  Google Scholar 

  8. Stillman MD, Barber J, Burns S, Williams S, Hoffman JM. Complications of spinal cord injury over the first year after discharge from inpatient rehabilitation. Arch Phys Med Rehabil. 2017 Sep;98(9):1800–5.

    Article  PubMed  Google Scholar 

  9. Wyndaele JJ, Kovindha A, Igawa Y, Madersbacher H, Radziszewski P, Ruffion A, et al. Neurologic fecal incontinence. NeurourolUrodyn. 2010;29(1):207–12.

    CAS  Google Scholar 

  10. Trivedi PM, Kumar L, Emmanuel AV. Altered colorectal compliance and anorectal physiology in upper and lower motor neurone spinal injury may explain bowel symptom pattern. Am J Gastroenterol. 2016;111(4):552–60.

    Article  PubMed  Google Scholar 

  11. Goyal RK. The enteric nervous system. N Engl J Med. 1996;334(17). https://doi.org/10.1056/NEJM199604253341707

  12. Rapps N, Van Oudenhove L, Enck P, Aziz Q. Brain imaging of visceral functions in healthy volunteers and IBS patients. J Psychosom Res. 2008 Jun;64(6):599–604.

    Article  PubMed  Google Scholar 

  13. Coggrave M, Norton C. Neurogenic bowel. In: Handbook of Clinical Neurology. Elsevier; 2013. p. 221–8. https://linkinghub.elsevier.com/retrieve/pii/B9780444529015000186.

    Google Scholar 

  14. Stiens SA, Bergman SB, Goetz LL. Neurogenic bowel dysfunction after spinal cord injury: clinical evaluation and rehabilitative management. Arch Phys Med Rehabil. 1997;78(3):S86–102.

    Article  CAS  PubMed  Google Scholar 

  15. Camilleri M, Bharucha A. Gastrointestinal dysfunction in neurologic disease. Semin Neurol. 1996 Sep;16(03):203–16.

    Article  CAS  PubMed  Google Scholar 

  16. Krogh K, Christensen P, Sabroe S, Laurberg S. Neurogenic bowel dysfunction score. Spinal Cord, 10. 2006;44:625–31.

  17. Miget G, Tan E, Pericolini M, Chesnel C, Haddad R, Turmel N, et al. The neurogenic bowel dysfunction score (NBD) is not suitable for patients with multiple sclerosis. Spinal Cord. 2022;60(12):1130–5.

    Article  PubMed  Google Scholar 

  18. Hubert K, Sideridis G, Sherlock R, et al. Validation of a bowel dysfunction instrument for adolescents with spina bifida. J Pediatr Urol. 2015;11(4):199.e1–7.

    Article  PubMed  Google Scholar 

  19. Kelly MS, Hannan M, Cassidy B, et al. Development, reliability, and validation of a neurogenic bowel dysfunction score in pediatric patients with spina bifida. NeurourolUrodyn. 2016;35(2):212–7.

    Google Scholar 

  20. •• Kurze I, Geng V, Böthig R. Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease. Spinal Cord. 2022;60(5):435–43. International Spinal Cord Society Guideline on the management of neurogenic bowel dysfunction. This is the first comprehensive guideline for the evaluation, diagnosis and management for NBD

    Article  PubMed  PubMed Central  Google Scholar 

  21. Krogh K, Emmanuel A, Perrouin-Verbe B, Korsten MA, Mulcahey MJ, Biering-Sørensen F. International spinal cord injury bowel function basic data set (Version 2.0). Spinal Cord. 2017 Jul;55(7):692–8.

    Article  CAS  PubMed  Google Scholar 

  22. Coggrave M, Norton C, Cody JD. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev. 2014; https://doi.org/10.1002/14651858.CD002115.pub5.

  23. Velde SV, Van Biervliet S, Van Renterghem K, Van Laecke E, Hoebeke P, Van Winckel M. Achieving fecal continence in patients with spina bifida: a descriptive cohort study. J Urol. 2007;178(6):2640–4.

    Article  Google Scholar 

  24. Bernardi M, Fedullo AL, Bernardi E, Munzi D, Peluso I, Myers J, et al. Diet in neurogenic bowel management: a viewpoint on spinal cord injury. World J Gastroenterol. 2020;26(20):2479–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Cameron KJ, Nyulasi IB, Collier GR, Brown DJ. Assessment of the effect of increased dietary fibre intake on bowel function in patients with spinal cord injury. Spinal Cord. 1996;34(5):277–83.

    Article  CAS  PubMed  Google Scholar 

  26. Emmanuel A. Rehabilitation in practice: managing neurogenic bowel dysfunction. Clin Rehabil. 2010;24(6):483–8.

    Article  PubMed  Google Scholar 

  27. Neurogenic bowel management in adults with spinal cord injury. J Spinal Cord Med. 1998;21(3):248–93.

  28. Gonring K, Dolan B, Kapke TL, Begotka A, Sood M, Silverman AH. Group treatment of fecal incontinence: a description of an interdisciplinary intervention. J Pediatr Gastroenterol Nutr. 2019;69(3):e70–4.

    Article  PubMed  Google Scholar 

  29. Ayaş Ş, Leblebici B, Sözay S, Bayramoğlu M, Niron EA. The effect of abdominal massage on bowel function in patients with spinal cord injury. Am J Phys Med Rehabil. 2006;85(12):951–5.

    Article  PubMed  Google Scholar 

  30. McClurg D, Hagen S, Hawkins S, Lowe-Strong A. Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study. Mult Scler J. 2011;17(2):223–33.

    Article  Google Scholar 

  31. Janssen TWJ, Prakken ES, Hendriks JMS, Lourens C, Van Der Vlist J, Smit CAJ. Electromechanical abdominal massage and colonic function in individuals with a spinal cord injury and chronic bowel problems. Spinal Cord. 2014;52(9):693–6.

    Article  CAS  PubMed  Google Scholar 

  32. Korsten MA, Singal AK, Monga A, Chaparala G, Khan AM, Palmon R, et al. Anorectal stimulation causes increased colonic motor activity in subjects with spinal cord injury. J Spinal Cord Med. 2007;30(1):31–5.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Faaborg PM, Christensen P, Krassioukov A, Laurberg S, Frandsen E, Krogh K. Autonomic dysreflexia during bowel evacuation procedures and bladder filling in subjects with spinal cord injury. Spinal Cord. 2014;52(6):494–8.

    Article  CAS  PubMed  Google Scholar 

  34. Zangaglia R, Martignoni E, Glorioso M, Ossola M, Riboldazzi G, Calandrella D, et al. Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study. Mov Disord. 2007;22(9):1239–44.

    Article  PubMed  Google Scholar 

  35. Glen House J, Stiens SA. Pharmacologically initiated defecation for persons with spinal cord injury: effectiveness of three agents. Arch Phys Med Rehabil. 1997;78:1062–5.

    Article  Google Scholar 

  36. Christensen P, Bazzocchi G, Coggrave M, Abel R, Hultling C, Krogh K, et al. A Randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord–injured patients. Gastroenterology. 2006;131(3):738–47.

    Article  PubMed  Google Scholar 

  37. Preziosi G, Gosling J, Raeburn A, Storrie J, Panicker J, Emmanuel A. Transanal irrigation for bowel symptoms in patients with multiple sclerosis. Dis Colon Rectum. 2012;55:1066–73.

    Article  PubMed  Google Scholar 

  38. Choi EK, Shin SH, Im YJ, Kim MJ, Han SW. The effects of transanal irrigation as a stepwise bowel management program on the quality of life of children with spina bifida and their caregivers. Spinal Cord. 2013;51(5):384–8.

    Article  CAS  PubMed  Google Scholar 

  39. Christensen P, Andreasen J, Ehlers L. Cost-effectiveness of transanal irrigation versus conservative bowel management for spinal cord injury patients. Spinal Cord. 2009;47(2):138–43.

    Article  CAS  PubMed  Google Scholar 

  40. Emmanuel A, Kumar G, Christensen P, Mealing S, Størling ZM, Andersen F, et al. Long-term cost-effectiveness of transanal irrigation in patients with neurogenic bowel dysfunction. PloS One. 2016;11(8):e0159394.

    Article  PubMed  PubMed Central  Google Scholar 

  41. • Emmanuel A, Kurze I, Krogh K, Ferreiro Velasco ME, Christensen P, Del Popolo G, et al. An open prospective study on the efficacy of Navina Smart, an electronic system for transanal irrigation, in neurogenic bowel dysfunction. PloS One. 2021;16(1):e0245453. Multi-institutional open label study for an electronic transanal irrigation system with promising results. This is one of the few recent advances in the management of NBD

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sinha CK, Grewal A, Ward HC. Antegrade continence enema (ACE): current practice. Pediatr Surg Int. 2008;24(6):685–8.

    Article  PubMed  Google Scholar 

  43. Bani-Hani AH, Cain MP, King S, Rink RC. Tap water irrigation and additives to optimize success with the malone antegrade continence enema: the Indiana University Algorithm. J Urol. 2008;180(4S):1757–60.

    Article  PubMed  Google Scholar 

  44. Chu DI, Balsara ZR, Routh JC, Ross SS, Wiener JS. Experience with glycerin for antegrade continence enema in patients with neurogenic bowel. J Urol. 2013;189(2):690–3.

    Article  CAS  PubMed  Google Scholar 

  45. Curry JI, Osborne A, Malone PSJ. The MACE procedure: experience in the United Kingdom. J Pediatr Surg. 1999;34(2):338–40.

    Article  CAS  PubMed  Google Scholar 

  46. Ok J, ha, Kurzrock EA. Objective measurement of quality of life changes after ACE Malone using the FICQOL survey. J Pediatr Urol. 2011;7(3):389–93.

    Article  PubMed  Google Scholar 

  47. Imai K, Shiroyanagi Y, Kim WJ, Ichiroku T, Yamazaki Y. Satisfaction after the Malone antegrade continence enema procedure in patients with spina bifida. Spinal Cord. 2014 Jan;52(1):54–7.

    Article  CAS  PubMed  Google Scholar 

  48. Chan DSY, Delicata RJ. Meta-analysis of antegrade continence enema in adults with faecal incontinence and constipation. Br J Surg. 2016;103(4):322–7.

    Article  CAS  PubMed  Google Scholar 

  49. Hoy NY, Metcalfe P, Kiddoo DA. Outcomes following fecal continence procedures in patients with neurogenic bowel dysfunction. J Urol. 2013;189(6):2293–7.

    Article  PubMed  Google Scholar 

  50. Branagan G, Tromans A, Finnis D. Effect of stoma formation on bowel care and quality of life in patients with spinal cord injury. Spinal Cord. 2003;41:680–3.

    Article  CAS  PubMed  Google Scholar 

  51. Cotterill N, Madersbacher H, Wyndaele JJ, Apostolidis A, Drake MJ, Gajewski J, et al. Neurogenic bowel dysfunction: clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013. NeurourolUrodyn. 2018;37(1):46–53.

    Google Scholar 

  52. Randell N, Lynch A, Anthony A, Dobbs B, Roake J, Frizelle F. Does a colostomy alter quality of life in patients with spinal cord injury? A controlled study. Spinal Cord. 2001;39(5):279–82.

    Article  CAS  PubMed  Google Scholar 

  53. Ku JH. The management of neurogenic bladder and quality of life in spinal cord injury. BJU Int. 2006;98(4):739–45.

    Article  PubMed  Google Scholar 

  54. Hamid R, Averbeck MA, Chiang H, Garcia A, Al Mousa RT, Oh SJ, et al. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. World J Urol. 2018;36(10):1517–27.

    Article  PubMed  Google Scholar 

  55. Razdan S, Leboeuf L, Meinbach DS, Weinstein D, Gousse AE. Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. Urology. 2003;61(5):893–6.

    Article  PubMed  Google Scholar 

  56. Yıldız N, Akkoç Y, Erhan B, Gündüz B, Yılmaz B, Alaca R, et al. Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up. Spinal Cord. 2014;52(6):462–7.

    Article  PubMed  Google Scholar 

  57. Paily A, Preziosi G, Trivedi P, Emmanuel A. Anti-muscarinic drugs increase rectal compliance and exacerbate constipation in chronic spinal cord injury. Spinal Cord. 2019;57(8):662–8.

    Article  PubMed  Google Scholar 

  58. Tate DG, Forchheimer M, Rodriguez G, Chiodo A, Cameron AP, Meade M, et al. Risk factors associated with neurogenic bowel complications and dysfunction in spinal cord injury. Arch Phys Med Rehabil. 2016;97(10):1679–86.

    Article  PubMed  Google Scholar 

  59. • Rodríguez-Ramallo H, Báez-Gutiérrez N, Prado-Mel E, Alfaro-Lara ER, Santos-Ramos B, Sánchez-Fidalgo S. Association between anticholinergic burden and constipation: a systematic review. Healthcare. 2021;9(5):581. A systematic review highlight the dose-dependent relationship between anticholinergic burden and constipation in non-neurogenic patients

  60. Trbovich M, Romo T, Polk M, Koek W, Kelly C, Stowe S, et al. The treatment of neurogenic lower urinary tract dysfunction in persons with spinal cord injury: an open label, pilot study of anticholinergic agent vs. mirabegron to evaluate cognitive impact and efficacy. Spinal Cord Ser Cases. 2021;7(1):1–10.

    Article  Google Scholar 

  61. Malde S, Marcelissen T, Vrijens D, Apostolidis A, Rahnama’I S, Cardozo L, et al. Sacral nerve stimulation for refractory OAB and idiopathic urinary retention: can phenotyping improve the outcome for patients: ICI-RS 2019? NeurourolUrodyn. 2020;39(S3):S96–103.

    Google Scholar 

  62. • Wang CN, Chung DE. Neuromodulation for lower urinary tract symptoms in special populations. NeurourolUrodyn. 2022;41(8):1948–57. A literature review of recent data of the use of neuromodulation in various neurogenic populations including multiple sclerosis, Parkisnon’s disease, and spinal cord injury

    Google Scholar 

  63. Southwell BR. Electro-neuromodulation for colonic disorders—review of meta-analyses, systematic reviews, and RCTs. Neuromodulation Technol Neural Interface. 2020;23(8):1061–81.

    Article  Google Scholar 

  64. Pauwels N, Willemse C, Hellemans S, Komen N, Van den Broeck S, Roenen J, et al. The role of neuromodulation in chronic functional constipation : a systematic review. Acta Gastro Enterol Belg. 2021;84(3):467–76.

    Article  CAS  Google Scholar 

  65. Chen G, Liao L. Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. Spinal Cord. 2015;53(3):204–8.

    Article  CAS  PubMed  Google Scholar 

  66. • Chen G, Liao L, Wang Y, Ying X. Effect of sacral neuromodulation on bowel dysfunction in patients with neurogenic bladder. Colorectal Dis. 2020;22(12):2155–60. A retrospective review of 41 patients with NBD and NLUTD with preoperative and postoperative NBD scores showing improvement in NBD symptoms with SNM

    Article  CAS  PubMed  Google Scholar 

  67. Chen G, Liao L, Deng H. The effect of sacral neuromodulation in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction. Urology. 2021 Jul;153:345–50.

    Article  PubMed  Google Scholar 

  68. • Masood I, Chen Q, Li J, Xu Z, Ying X, Wang Y, et al. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction: a multicenter retrospective study from China. Neuromodulation Technol Neural Interface. 2021;24(7):1278–83. A retrospective analysis of 152 subjects with neurogenic bladder of multiple etiologies showing 62% success with >50% improvement in NBD score

    Article  Google Scholar 

  69. Ren J, Chew DJ, Biers S, Thiruchelvam N. Electrical nerve stimulation to promote micturition in spinal cord injury patients: a review of current attempts. NeurourolUrodyn. 2016;35(3):365–70.

    Google Scholar 

  70. Rijkhoff NJM. Neuroprostheses to treat neurogenic bladder dysfunction: current status and future perspectives. Childs Nerv Syst. 2004;20(2):75–86.

    Article  PubMed  Google Scholar 

  71. Gaunt RA, Prochazka A. Control of urinary bladder function with devices: successes and failures. In: Weaver LC, Polosa C, editors. Progress in Brain Research. (Autonomic dysfunction after spinal cord injury; vol. 152). Elsevier; 2006. p. 163–94. https://www.sciencedirect.com/science/article/pii/S0079612305520119.

    Chapter  Google Scholar 

  72. Wheeler TL, de Groat W, Eisner K, Emmanuel A, French J, Grill W, et al. Translating promising strategies for bowel and bladder management in spinal cord injury. Exp Neurol. 2018;1(306):169–76.

    Article  Google Scholar 

  73. Rasmussen MM, Kutzenberger J, Krogh K, Zepke F, Bodin C, Domurath B, et al. Sacral anterior root stimulation improves bowel function in subjects with spinal cord injury. Spinal Cord. 2015;53(4):297–301.

    Article  CAS  PubMed  Google Scholar 

  74. Sanford MT, Suskind AM. Neuromodulation in neurogenic bladder. Transl Androl Urol. 2016;5(1):11726–126.

    Google Scholar 

  75. Tudor KI, Seth JH, Liechti MD, Ochulor J, Gonzales G, Haslam C, et al. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder. Clin Auton Res. 2020;30(1):61–7.

    Article  PubMed  Google Scholar 

  76. Hotouras A, Murphy J, Walsh U, Allison M, Curry A, Williams NS, et al. Outcome of percutaneous tibial nerve stimulation (PTNS) for fecal incontinence: a prospective cohort study. Ann Surg. 2014;259(5):939.

    Article  PubMed  Google Scholar 

  77. Edenfield AL, Amundsen CL, Wu JM, Levin PJ, Siddiqui NY. Posterior tibial nerve stimulation for the treatment of fecal incontinence: a systematic evidence review. Obstet Gynecol Surv. 2015;70(5):329.

    Article  PubMed  Google Scholar 

  78. • Sacco R, Braga A, Disanto G, Digesu GA, Maino P, Koetsier E, et al. Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients. Mult Scler Houndmills Basingstoke Engl. 2021;27(10):1577–84. Prospective study showing benefit of PTNS for both fecal incontinence and functional constipation in 60 patients with MS

    Article  CAS  Google Scholar 

  79. Moya P, Parra P, Arroyo A, Peña E, Benavides J, Calpena R. Sacral nerve stimulation versus percutaneous posterior tibial nerve stimulation in the treatment of severe fecal incontinence in men. Tech Coloproctol. 2016;20(5):317–9.

    Article  CAS  PubMed  Google Scholar 

  80. Simillis C, Lal N, Qiu S, Kontovounisios C, Rasheed S, Tan E, et al. Sacral nerve stimulation versus percutaneous tibial nerve stimulation for faecal incontinence: a systematic review and meta-analysis. Int J Colorectal Dis. 2018;33(5):645–8.

    Article  PubMed  Google Scholar 

  81. Steadman CJ, Grill WM. Spinal cord stimulation for the restoration of bladder function after spinal cord injury. Healthc Technol Lett. 2020;7(3):87–92.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Harkema S, Gerasimenko Y, Hodes J, Burdick J, Angeli C, Chen Y, et al. Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study. The Lancet. 2011;377(9781):1938–47.

    Article  Google Scholar 

  83. Darrow D, Balser D, Netoff TI, Krassioukov A, Phillips A, Parr A, et al. Epidural spinal cord stimulation facilitates immediate restoration of dormant motor and autonomic supraspinal pathways after chronic neurologically complete spinal cord injury. J Neurotrauma. 2019;36(15):2325–36.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Walter M, Lee AHX, Kavanagh A, Phillips AA, Krassioukov AV. Epidural spinal cord stimulation acutely modulates lower urinary tract and bowel function following spinal cord injury: a case report. Front Physiol. 2018; https://doi.org/10.3389/fphys.2018.01816.

  85. Niu T, Bennett CJ, Keller TL, Leiter JC, Lu DC. A proof-of-concept study of transcutaneous magnetic spinal cord stimulation for neurogenic bladder. Sci Rep. 2018;8(1):12549.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Gad PN, Kreydin E, Zhong H, Latack K, Edgerton VR. Non-invasive neuromodulation of spinal cord restores lower urinary tract function after paralysis. Front Neurosci. 2018:12. https://doi.org/10.3389/fnins.2018.00432.

  87. Kreydin E, Zhong H, Lavrov I, Edgerton VR, Gad P. The effect of non-invasive spinal cord stimulation on anorectal function in individuals with spinal cord injury: a case series. Front Neurosci. 2022;17(16):816106.

    Article  Google Scholar 

  88. Kreydin E, Zhong H, Latack K, Ye S, Edgerton VR, Gad P. Transcutaneous electrical spinal cord neuromodulator (TESCoN) improves symptoms of overactive bladder. Front Syst Neurosci. 2020;14 https://doi.org/10.3389/fnsys.2020.00001.

  89. Bourbeau D, Bolon A, Creasey G, Dai W, Fertig B, French J, et al. Needs, priorities, and attitudes of individuals with spinal cord injury toward nerve stimulation devices for bladder and bowel function: a survey. Spinal Cord. 2020;58(11):1216–26.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Wu SY, Kuo HC. A real-world experience with augmentation enterocystoplasty—high patient satisfaction with high complication rates. NeurourolUrodyn. 2018;37(2):744–50.

    Google Scholar 

  91. Roberts JP, Moon S, Malone PS. Treatment of neuropathic urinary and faecal incontinence with synchronous bladder reconstruction and the antegrade continence enema procedure. Br J Urol. 1995;75(3):386–9.

    Article  CAS  PubMed  Google Scholar 

  92. Kajbafzadeh AM, Chubak N. Simultaneous Malone antegrade continent enema and Mitrofanoff principle using the divided appendix: report of a new technique for prevention of stoma complications. J Urol. 2001;165(6 Pt 2):2404–9.

    Article  CAS  PubMed  Google Scholar 

  93. Lorenzo AJ, Chait PG, Wallis MC, Raikhlin A, Farhat WA. Minimally invasive approach for treatment of urinary and fecal incontinence in selected patients with spina bifida. Urology. 2007;70(3):568–71.

    Article  PubMed  Google Scholar 

  94. Fung B, Kessler TM, Haeni K, Burkhard FC, Studer UE. Bowel function remains subjectively unchanged after ileal resection for construction of continent ileal reservoirs. Eur Urol. 2011;60(3):585–90.

    Article  PubMed  Google Scholar 

  95. Roth S, Semjonow A, Waldner M, Hertle L. Risk of bowel dysfunction with diarrhea after continent urinary diversion with ileal and ileocecal segments. J Urol. 1995;154(5):1696–9.

    Article  CAS  PubMed  Google Scholar 

  96. N’Dow J, Leung HY, Marshall C, Neal DE. Bowel dysfunction after bladder reconstruction. J Urol. 1998;159(5):1470–4. discussion 1474-1475

    Article  PubMed  Google Scholar 

  97. Malbert C, h. The ileocolonic sphincter. Neurogastroenterol Motil. 2005;17(s1):41–9.

    Article  PubMed  Google Scholar 

  98. Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, Richard F, Denys P. Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord. 2000;38(8):490–4.

    Article  CAS  PubMed  Google Scholar 

  99. Krebs J, Bartel P, Pannek J. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. NeurourolUrodyn. 2016;35(2):260–6.

    Google Scholar 

  100. Somani BK, Kumar V, Wong S, Pickard R, Ramsay C, Nabi G, et al. Bowel dysfunction after transposition of intestinal segments into the urinary tract: 8-year prospective cohort study. J Urol. 2007;177(5):1793–8.

    Article  PubMed  Google Scholar 

  101. • Perrouin-Verbe MA, Léon P, Denys P, Mongiat-Artus P, Chartier-Kastler E, Phé V. Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: a single-center experience in a multidisciplinary team. NeurourolUrodyn. 2019;38(1):330–7. Long-term follow up of enterocystoplasty with a mean of 13 years of follow-up showing no change in bowel function and high rates of satisfaction in patients with spina bifida

    Google Scholar 

  102. • Myers JB, Lenherr SM, Stoffel JT, Elliott SP, Presson AP, Zhang C, et al. The effects of augmentation cystoplasty and botulinum toxin injection on patient-reported bladder function and quality of life among individuals with spinal cord injury performing clean intermittent catheterization. NeurourolUrodyn. 2019;38(1):285–94. Comparison of almost 900 patients in the neurogenic bladder research group receiving either CIC alone or with botox, or enterocystoplasty showing high rates of bowel dysfunction in the cystoplasty group

    CAS  Google Scholar 

  103. Zhang P, Yang Y, Wu Z, jin, Zhang N, Zhang C hua, Zhang X dong. Long-term follow-up of sigmoid bladder augmentation for low-compliance neurogenic bladder. Urology. 2014;84(3):697–701.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Stanford University School of Medicine, Stanford, CA, USA

    Claire S. Burton & Craig V. Comiter

  2. Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA

    Shayan Khorsandi

Authors
  1. Claire S. Burton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shayan Khorsandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Craig V. Comiter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claire S. Burton.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burton, C.S., Khorsandi, S. & Comiter, C.V. Impact of Neurogenic Lower Urinary Tract Dysfunction on Bowel Symptoms. Curr Bladder Dysfunct Rep 18, 259–268 (2023). https://doi.org/10.1007/s11884-023-00702-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-023-00702-w

Keywords

Search

Navigation